Rigense
Back to all news
NewsJust inMedium impact

AbbVie (ABBV) to Showcase Expanded Solid Tumor Research at ESMO Congress

gurufocus.com·1 hour ago·Unknown·1 min read
Rigense market context
News
No image available. Showing a neutral Rigense placeholder.

On October 18, 2026, AbbVie Inc (NYSE: ABBV) announced it will present new and updated data from its extensive solid tumor research portfolio at the upcoming Eu

Read original source

Related news